Peter G. Klimko
- Organic Chemistry
- Molecular Biology
- Ophthalmology top 5%
- Pharmacology top 10%
- Public Health, Environmental and Occupational Health
- Co-authors
- Najam A. SharifBrenda Walker GriffinJulie Y. CriderDaniel A. SingletonCharles S. SwindellMark R. HellbergWeiming FanTom R. Dean
- Topics
- Inflammatory mediators and NSAID effects (7 papers)Glaucoma and retinal disorders (5 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
- Journals
- Journal of Medicinal ChemistryJournal of Pharmacology and Experimental TherapeuticsThe Journal of Organic Chemistry
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Peter G. Klimko
17 papers receiving 414 citations
Peers
Comparison fields: 5 of 69
- Organic Chemistry 136
- Molecular Biology 125
- Ophthalmology 118
- Pharmacology 93
- Public Health, Environmental and Occupational Health 62
Countries citing papers authored by Peter G. Klimko
This map shows the geographic impact of Peter G. Klimko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Klimko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Klimko more than expected).
Fields of papers citing papers by Peter G. Klimko
This network shows the impact of papers produced by Peter G. Klimko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Klimko. The network helps show where Peter G. Klimko may publish in the future.
Co-authorship network of co-authors of Peter G. Klimko
This figure shows the co-authorship network connecting the top 25 collaborators of Peter G. Klimko. A scholar is included among the top collaborators of Peter G. Klimko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter G. Klimko. Peter G. Klimko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 43 | |
| 3 | 1 | |
| 4 | 15 | |
| 5 | 28 | |
| 6 | 18 | |
| 7 | 7 | |
| 8 | 39 | |
| 9 | 9 | |
| 10 | 53 | |
| 11 | AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. | 86 |
| 12 | 1 | |
| 13 | 20 | |
| 14 | 24 | |
| 15 | 5 | |
| 16 | 14 | |
| 17 | 31 |
About Peter G. Klimko
Peter G. Klimko is a scholar working on Biochemistry, Ophthalmology and Pharmacology, having authored 17 papers that have together received 426 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Glaucoma and retinal disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Ophthalmology (118 citations), Pharmacology (93 citations) and Organic Chemistry (136 citations). Peter G. Klimko has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Najam A. Sharif, Brenda Walker Griffin, Julie Y. Crider, Daniel A. Singleton, Charles S. Swindell, Mark R. Hellberg, Weiming Fan, Tom R. Dean, Gustav Graff and Marsha A. McLaughlin. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.